[go: up one dir, main page]

MX2018004489A - Extracto de agavaceae que comprende saponinas esteroidales y su uso para tratar y/o prevenir patologías relacionadas con desórdenes metabólicos. - Google Patents

Extracto de agavaceae que comprende saponinas esteroidales y su uso para tratar y/o prevenir patologías relacionadas con desórdenes metabólicos.

Info

Publication number
MX2018004489A
MX2018004489A MX2018004489A MX2018004489A MX2018004489A MX 2018004489 A MX2018004489 A MX 2018004489A MX 2018004489 A MX2018004489 A MX 2018004489A MX 2018004489 A MX2018004489 A MX 2018004489A MX 2018004489 A MX2018004489 A MX 2018004489A
Authority
MX
Mexico
Prior art keywords
extract
agavaceae
related pathologies
treat
metabolic disorder
Prior art date
Application number
MX2018004489A
Other languages
English (en)
Inventor
Maria Leal Diaz Ana
Alejandra Gutierrez Uribe Janet
Torres Y Torres Nimbe
Roberto Tovar Palacio Armando
Guadalupe Noriega Lopez Lilia
Original Assignee
Inst Tecnologico Estudios Superiores Monterrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Tecnologico Estudios Superiores Monterrey filed Critical Inst Tecnologico Estudios Superiores Monterrey
Publication of MX2018004489A publication Critical patent/MX2018004489A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • B01D11/0288—Applications, solvents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un extracto de saponinas y sapogeninas obtenido de las plantas de la familia Agavaceae en la forma de un extracto o en su forma purificada que tiene efectos beneficiosos sobre el organismo de los mamíferos en lo referente a la prevención o tratamiento de los trastornos metabólicos como la obesidad, síndrome metabólico, la diabetes y sus patologías relacionadas en los mamíferos, incluyendo seres humanos y más efectos beneficiosos en el metabolismo de los lípidos, metabolismo de la glucosa, gasto de energía y salud de la microbiota intestinal. Otros aspectos de la invención comprenden un extracto compuesto por dichas saponinas y sapogeninas, así como los métodos para el uso de dicho extracto.
MX2018004489A 2015-10-16 2015-10-16 Extracto de agavaceae que comprende saponinas esteroidales y su uso para tratar y/o prevenir patologías relacionadas con desórdenes metabólicos. MX2018004489A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/002111 WO2017064530A1 (en) 2015-10-16 2015-10-16 Agavaceae extract comprising steroidal saponins to treat or prevent metabolic disorder related pathologies

Publications (1)

Publication Number Publication Date
MX2018004489A true MX2018004489A (es) 2019-01-21

Family

ID=58517886

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004489A MX2018004489A (es) 2015-10-16 2015-10-16 Extracto de agavaceae que comprende saponinas esteroidales y su uso para tratar y/o prevenir patologías relacionadas con desórdenes metabólicos.

Country Status (3)

Country Link
US (1) US20190060341A1 (es)
MX (1) MX2018004489A (es)
WO (1) WO2017064530A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108125977A (zh) * 2018-01-31 2018-06-08 烟台市华昕生物医药科技有限公司 川续断皂苷x在制备和治疗急慢性肝损伤及肝纤维化药物中的应用
KR102282638B1 (ko) * 2020-04-13 2021-07-27 가천대학교 산학협력단 베이지 지방세포 및 갈색 지방세포 분화조절용 조성물, 분화 유도방법, 및 이를 포함한 체지방 감소 및 비만 예방용 약학 조성물
MX2022016058A (es) * 2020-06-19 2023-02-02 Kimberly Clark Co Procesos para la extraccion y recuperacion de extractos de hesperaloe.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131237C (zh) * 1997-09-26 2003-12-17 中国人民解放军军事医学科学院放射医学研究所 甾体皂甙防治老年性痴呆的用途及新的甾体皂甙
US20040096527A1 (en) * 2001-02-27 2004-05-20 Jin-Hyuck Jang Compositions for lowering serum cholesterol level
CN1754541A (zh) * 2004-09-30 2006-04-05 成都地奥制药集团有限公司 甾体皂苷药物组合物及其制备方法和用途
US8470858B2 (en) * 2008-09-09 2013-06-25 Albino Vargas Ozuna Agave syrup extract having anticancer activity
US9585928B2 (en) * 2007-11-09 2017-03-07 Instituto Technologico Y De Estudios Superiores De Monterrey Agave syrup extract having anticancer activity
CN101845076A (zh) * 2010-05-21 2010-09-29 中山以诺生物科技有限公司 催化氧化降解甾体总皂甙制备次生甾体皂苷和皂苷元的方法

Also Published As

Publication number Publication date
WO2017064530A1 (en) 2017-04-20
US20190060341A1 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
PH12020500352A1 (en) Therapeutic uses of empagliflozin
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
MX386086B (es) Composicion de cannabis
JO3686B1 (ar) جلوكان ومركبات مساعِدات glp-1 مشتركة
PH12013500808A1 (en) Pharmaceutical combinations for the treatment of metabolic disorders
MX382123B (es) Esteroides neuroactivos, composiciones y usos de los mismos.
WO2019066577A3 (ko) 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물
AU2018270408A1 (en) Methods of inhibiting aging and treating aging-related disorders
MX2015013948A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
WO2011140655A8 (en) Phenolic compositions derived from apple skin and uses thereof
HK1216506A1 (zh) 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用
EA201690964A1 (ru) Композиции и способы для уменьшения серьезных неблагоприятных сердечно-сосудистых явлений
NZ589311A (en) Angiogenin-enriched milk fractions prepared by methods involving heating the milk to over 70 degrees celsius for at least one minute
BR112014015354A2 (pt) composição de extratos enriquecidos com elagitaninos no bem-estar sexual
BRPI0908541B8 (pt) uso de panax quinquefolius ou uma fração do mesmo na ativação de respostas imunes inatas e adaptativas
BR112018000786A2 (pt) métodos e composições usando bifidobacterium longum para modular a reatividade emocional e tratar ou evitar perturbações subclínicas do estado de humor
MY193613A (en) Synergistic composition for osteoarthritis
PH12019501295A1 (en) Nutritional compositions containing butyrate and/or lactoferrin and uses thereof
BR112017018758A2 (pt) alteração do metabolismo de esteroide para tratamento de doença dependente de esteroide
PH12015502351A1 (en) Herbal compositions for treating pain and skin disorders
MX2018004489A (es) Extracto de agavaceae que comprende saponinas esteroidales y su uso para tratar y/o prevenir patologías relacionadas con desórdenes metabólicos.
PH12017500795A1 (en) Compound having gpr119 agonistic activity, method for preparing the same, and pharmaceutical composition including the same as effective component
BR112018007768A2 (pt) composições e métodos para tratamento de homocistinúria
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
MX2016012127A (es) Ostreolisina, variante de la misma funcionalmente relacionada, extracto que comprende ostreolisina y usos de los mismos.